Methylprednisolone Sodium Succinate Injection, Powder, For Solution
Product Images NDC 70518-4345

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Methylprednisolone Sodium Succinate (NDC 70518-4345). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a description of a medication called Methylprednisolone Sodium Succinate Injection. Each vial contains 125 mg of the medication. The package includes 25 vials, each containing 2 mL. The medication should be protected from light and the unused portion should be discarded. It is for intramuscular or intravenous use only, and should be used within 48 hours after mixing as it comes in single-dose vials. The manufacturer is Hikima located in Berkeley Heights, NJ. The medication should be stored at a temperature between 20-25°C (68-77°F), with excursions permitted to 15-30°C (59-86°F). Additionally, the package should be kept out of the reach of children.*
FDA Label Image

Mm2 (Methylprednisolone Sodium Succinate 125mg Per Vial 70518 4345 01)

Mm2 (Methylprednisolone Sodium Succinate 125mg Per Vial 70518 4345 01)
This is a description for a vial of Methylprednisolone Sodium Succinate injection with a strength of 125 mg. It is intended for intramuscular or intravenous use and should be used within 48 hours after mixing. The medication should be protected from light, and any unused portion should be discarded. The usual dosage information can be found in the insert. The product has been repackaged by RemedyRepack Inc., and the manufacturer is Hikima located in Berkeley Heights, NJ. The medication should be kept out of reach of children and stored at a temperature of 20-25°C (68-77°F) with excursions permitted to 15-30°C (59-86°F).*
FDA Label Image

Chemical Structure (Methylprednisolone Sodium Succinate For Injection 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.